ASCO 2014: A phase Ib dose escalation trial of SAR650984 in combination with len/dex in RR MM
Thomas G. Martin, MD
University of California SF
San Francisco, California, USA
A phase Ib dose escalation trial of SAR650984 (Anti-CD-38 mAb) in combination with lenalidomide and dexamethasone i...
Author: InternationalMyelomaFoundation
Added: 09/10/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts